We hope when people understand more about what the disease is and how it can be prevented that their concerns will have been allayed.

It's getting people to notice the product. If the wine in the bottle isn't good, they'll only buy it once.

Patients (in the study) went through an induction and maintenance phase (consisting of fewer drugs), while patients now continue on a chronic three-drug therapy. If somebody is failing chronic administration of three drugs, it could be that they have mutations from all of the components.